Your browser doesn't support javascript.
loading
Consensus classification of posterior cortical atrophy.
Crutch, Sebastian J; Schott, Jonathan M; Rabinovici, Gil D; Murray, Melissa; Snowden, Julie S; van der Flier, Wiesje M; Dickerson, Bradford C; Vandenberghe, Rik; Ahmed, Samrah; Bak, Thomas H; Boeve, Bradley F; Butler, Christopher; Cappa, Stefano F; Ceccaldi, Mathieu; de Souza, Leonardo Cruz; Dubois, Bruno; Felician, Olivier; Galasko, Douglas; Graff-Radford, Jonathan; Graff-Radford, Neill R; Hof, Patrick R; Krolak-Salmon, Pierre; Lehmann, Manja; Magnin, Eloi; Mendez, Mario F; Nestor, Peter J; Onyike, Chiadi U; Pelak, Victoria S; Pijnenburg, Yolande; Primativo, Silvia; Rossor, Martin N; Ryan, Natalie S; Scheltens, Philip; Shakespeare, Timothy J; Suárez González, Aida; Tang-Wai, David F; Yong, Keir X X; Carrillo, Maria; Fox, Nick C.
Afiliación
  • Crutch SJ; Dementia Research Centre, UCL Institute of Neurology, London, UK. Electronic address: s.crutch@ucl.ac.uk.
  • Schott JM; Dementia Research Centre, UCL Institute of Neurology, London, UK.
  • Rabinovici GD; Department of Neurology, Memory & Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Murray M; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Snowden JS; Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust, Salford, UK; Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK.
  • van der Flier WM; Department of Neurology, VU University Medical Centre, Amsterdam Neuroscience, Amsterdam, The Netherlands; Alzheimer Center, VU University Medical Centre, Amsterdam Neuroscience, Amsterdam, The Netherlands.
  • Dickerson BC; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
  • Ahmed S; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Bak TH; Human Cognitive Neuroscience, School of Philosophy, Psychology and Language Sciences, University of Edinburgh, Edinburgh, UK.
  • Boeve BF; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Butler C; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Cappa SF; Center for Cognitive Neuroscience, Vita-Salute San Raffaele University, Milan, Italy.
  • Ceccaldi M; INSERM U 1106, Institut des Neurosciences des Systèmes, Aix Marseille Université, Marseilles, France.
  • de Souza LC; Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Dubois B; Institute for Memory and Alzheimer's Disease, UMR-S975, Salpêtrière Hospital, Pierre & Marie Curie University, Paris, France.
  • Felician O; Aix-Marseille Université, INSERM, Institut de Neurosciences des Systèmes, Marseille, France; AP-HM Hôpitaux de la Timone, Service de Neurologie et Neuropsychologie, Marseille, France.
  • Galasko D; Department of Neurosciences, University of California, San Diego, San Diego, USA.
  • Graff-Radford J; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Hof PR; Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, USA; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
  • Krolak-Salmon P; Clinical and Research Memory Center of Lyon, Hospices Civils de Lyon, INSERM U1028, CNRS UMR5292, University of Lyon, Lyon, France.
  • Lehmann M; Dementia Research Centre, UCL Institute of Neurology, London, UK; Department of Neurology, Memory & Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Magnin E; Department of Neurology, Regional Memory Centre (CMRR), CHU Besançon, Besançon, France.
  • Mendez MF; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Nestor PJ; Cognitive Neurology and Neurodegeneration Group, German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Onyike CU; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Pelak VS; Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Pijnenburg Y; Department of Neurology, VU University Medical Centre, Amsterdam Neuroscience, Amsterdam, The Netherlands; Alzheimer Center, VU University Medical Centre, Amsterdam Neuroscience, Amsterdam, The Netherlands.
  • Primativo S; Dementia Research Centre, UCL Institute of Neurology, London, UK.
  • Rossor MN; Dementia Research Centre, UCL Institute of Neurology, London, UK.
  • Ryan NS; Dementia Research Centre, UCL Institute of Neurology, London, UK.
  • Scheltens P; Department of Neurology, VU University Medical Centre, Amsterdam Neuroscience, Amsterdam, The Netherlands; Alzheimer Center, VU University Medical Centre, Amsterdam Neuroscience, Amsterdam, The Netherlands.
  • Shakespeare TJ; Dementia Research Centre, UCL Institute of Neurology, London, UK.
  • Suárez González A; Dementia Research Centre, UCL Institute of Neurology, London, UK; Memory Disorders Unit, Neurology Department, University Hospital Virgen del Rocio, Seville, Spain.
  • Tang-Wai DF; Division of Neurology, University Health Network Memory Clinic, University of Toronto, Toronto, Ontario, Canada.
  • Yong KXX; Dementia Research Centre, UCL Institute of Neurology, London, UK.
  • Carrillo M; Medical and Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
  • Fox NC; Dementia Research Centre, UCL Institute of Neurology, London, UK.
Alzheimers Dement ; 13(8): 870-884, 2017 Aug.
Article en En | MEDLINE | ID: mdl-28259709
INTRODUCTION: A classification framework for posterior cortical atrophy (PCA) is proposed to improve the uniformity of definition of the syndrome in a variety of research settings. METHODS: Consensus statements about PCA were developed through a detailed literature review, the formation of an international multidisciplinary working party which convened on four occasions, and a Web-based quantitative survey regarding symptom frequency and the conceptualization of PCA. RESULTS: A three-level classification framework for PCA is described comprising both syndrome- and disease-level descriptions. Classification level 1 (PCA) defines the core clinical, cognitive, and neuroimaging features and exclusion criteria of the clinico-radiological syndrome. Classification level 2 (PCA-pure, PCA-plus) establishes whether, in addition to the core PCA syndrome, the core features of any other neurodegenerative syndromes are present. Classification level 3 (PCA attributable to AD [PCA-AD], Lewy body disease [PCA-LBD], corticobasal degeneration [PCA-CBD], prion disease [PCA-prion]) provides a more formal determination of the underlying cause of the PCA syndrome, based on available pathophysiological biomarker evidence. The issue of additional syndrome-level descriptors is discussed in relation to the challenges of defining stages of syndrome severity and characterizing phenotypic heterogeneity within the PCA spectrum. DISCUSSION: There was strong agreement regarding the definition of the core clinico-radiological syndrome, meaning that the current consensus statement should be regarded as a refinement, development, and extension of previous single-center PCA criteria rather than any wholesale alteration or redescription of the syndrome. The framework and terminology may facilitate the interpretation of research data across studies, be applicable across a broad range of research scenarios (e.g., behavioral interventions, pharmacological trials), and provide a foundation for future collaborative work.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encefalopatías Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encefalopatías Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2017 Tipo del documento: Article